Last Updated:

COVID-19: US Company To Start Injecting Healthy Volunteers With A Potential Vaccine

Amidst the COVID-19 pandemic, a small Pennsylvania company has just received regulatory clearance to start clinical testing for a potential vaccine.

Company begins human trials on potential coronavirus vaccine

Amidst the coronavirus pandemic, a small Pennsylvania company has just received regulatory clearance to start clinical testing for a coronavirus vaccine. According to reports, the company will begin injecting healthy volunteers with a potential coronavirus vaccine. The first person received the first dose of the experimental vaccine on April 6.

Second vaccine to begin human trials

As per reports, the vaccine was developed by Inovio Pharmaceuticals, the company has been able to achieve this through the funding it received from the Bill and Melinda Gates Foundation as well as the Coalition for Epidemic Preparedness Innovations. According to reports, the vaccine by Inovio is called INO-4800 and is the second potential coronavirus vaccine to start human trials in the United States. For the clinical trial, the company is taking the help of 40 healthy adult volunteers. Each volunteer will receive two doses of the experimental vaccine, four weeks apart.

Read: Kartik Aaryan Dreams About Finding Coronavirus Vaccine; Fans Wish For It To Come True

Read: Madonna Joins Forces With Bill & Melinda Gates Foundation To Help Create COVID-19 Vaccine

The company expects results from the study as early as late summer. It the initial results are positive then the company will initiate another series of tests meant to assess the vaccine’s efficacy against the vaccine. In case the vaccine does prove to be effective, Inovio will also be faced with the challenge of manufacturing the vaccine so as to meet global demand. Since the coronavirus pandemic is so widespread, a vaccine would also be in very high demand.

As per reports, Inovio in an effort to meet this demand plans to scale up its production and have 1 million vaccine doses ready by the end of 2020. But even if everything in the trials progresses smoothly, clinical testing will take at least a year or up to 18 months in order to determine if the potential vaccine is safe for use on humans and effective against the coronavirus. The deadly coronavirus pandemic that began in China last year has infected 1,349,584 worldwide and caused the deaths of 74,808 people.

Read: Fact Check: Does The Coronavirus Study In France Prove Chloroquine To Be The Vaccine?

Read: British-American Companies Join Race To Develop Tobacco-based Coronavirus Vaccine

(Image Credit: Pixabay)

First Published:
By 2030, 40% Indians will not have access to drinking water